Guest author Seth Lederman, MD, calls Long COVID "one of the most pressing global health threats I have seen since fighting HIV/AIDS."
Seth Lederman, MD
Advertisement
Seth Lederman, MD, is a physician-scientist and CEO of New Jersey-based Tonix Pharmaceuticals, a company developing technologies to prevent COVID-19 and treat Long COVID.
Articles by Seth Lederman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Top Infectious Disease News Stories Week of October 11-October 17
3
Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program
4
